Explore more publications!
STEM Minnesota
Submit Press Release

STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 20, 2025

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
November 20, 2025

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids

Indeterminate GlobeNewswire
BioSyent Releases Financial Results for Q3 and YTD 2025
November 20, 2025

BioSyent Releases Financial Results for Q3 and YTD 2025

Indeterminate GlobeNewswire
BioSyent Declares Fourth Quarter 2025 Dividend
November 20, 2025

BioSyent Declares Fourth Quarter 2025 Dividend

Indeterminate GlobeNewswire
NVIDIA Announces Upcoming Event for Financial Community
November 20, 2025

NVIDIA Announces Upcoming Event for Financial Community

Indeterminate GlobeNewswire
TruGolf Strengthens Golf Industry Technology Leadership as Its Core Software Powers Sky Sports’ Award-Winning Coverage of the 2025 Open Championship at Royal Portrush
November 20, 2025

TruGolf Strengthens Golf Industry Technology Leadership as Its Core Software Powers Sky Sports’ Award-Winning Coverage of the 2025 Open Championship at Royal Portrush

Indeterminate GlobeNewswire
Equillium to Participate in Upcoming Investor Conferences
November 20, 2025

Equillium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
ESCO Reports Fourth Quarter And Fiscal 2025 Results
November 20, 2025

ESCO Reports Fourth Quarter And Fiscal 2025 Results

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
November 20, 2025

Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
November 20, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome
November 20, 2025

Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome

Indeterminate GlobeNewswire
MDB Capital Holdings Provides Third Quarter 2025 Update
November 20, 2025

MDB Capital Holdings Provides Third Quarter 2025 Update

Indeterminate GlobeNewswire
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
November 20, 2025

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Indeterminate GlobeNewswire
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
November 20, 2025

Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension

Indeterminate GlobeNewswire
Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference
November 20, 2025

Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference

Indeterminate GlobeNewswire
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
November 20, 2025

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

Indeterminate GlobeNewswire
Keros Therapeutics Announces Final Results of Tender Offer
November 20, 2025

Keros Therapeutics Announces Final Results of Tender Offer

Indeterminate GlobeNewswire
Blue Lake Casino & Hotel and Quick Custom Intelligence (QCI) Extend Partnership to Further Enhance Guest Experience and Drive Profitability
November 20, 2025

Blue Lake Casino & Hotel and Quick Custom Intelligence (QCI) Extend Partnership to Further Enhance Guest Experience and Drive Profitability

Indeterminate GlobeNewswire
Orobit Secures Global Distribution: Stables Becomes Exclusive Fiat Gateway Across 150+ Countries
November 20, 2025

Orobit Secures Global Distribution: Stables Becomes Exclusive Fiat Gateway Across 150+ Countries

Indeterminate GlobeNewswire
Senvix Unveiled: How This Senvix AI Platform Is Empowering Global Traders with Data-Driven Confidence
November 20, 2025

Senvix Unveiled: How This Senvix AI Platform Is Empowering Global Traders with Data-Driven Confidence

Indeterminate GlobeNewswire
Envariax Unveiled: Why Envariax Is the Next Big Leap in Algorithmic Trading
November 20, 2025

Envariax Unveiled: Why Envariax Is the Next Big Leap in Algorithmic Trading

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions